Patents by Inventor Julia Hepp

Julia Hepp has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220298212
    Abstract: The present disclosure relates to recombinant binding proteins comprising a designed ankyrin repeat domain with binding specificity for 4-1 BB (CD 137). In addition, the disclosure relates to nucleic acids encoding such binding proteins, pharmaceutical compositions comprising such binding proteins or nucleic acids, and the use of such binding proteins, nucleic acids or pharmaceutical compositions in methods for activating 4-1 BB in cells expressing 4-1 BB, e.g., tumor-localized T-lymphocytes, and for treating or diagnosing diseases, such as cancer, in a mammal, including a human.
    Type: Application
    Filed: June 3, 2020
    Publication date: September 22, 2022
    Inventors: Christian REICHEN, Alexander LINK, Julia HEPP, Victor LEVITSKY
  • Publication number: 20200385488
    Abstract: This disclosure relates to multispecific recombinant proteins useful for the treatment of cancer.
    Type: Application
    Filed: June 3, 2020
    Publication date: December 10, 2020
    Inventors: Christian Reichen, Alexander Link, Julia Hepp, Victor Levitsky
  • Patent number: 10138297
    Abstract: The present invention relates to a human monoclonal antibody or fragment thereof which specifically binds to and neutralizes primate GM-CSF.
    Type: Grant
    Filed: May 21, 2015
    Date of Patent: November 27, 2018
    Assignee: AMGEN RESEARCH (MUNICH) GMBH
    Inventors: Tobias Raum, Julia Hepp (nee Henckel), Eva Vieser (nee Krinner), Silke Petsch (nee Mittelstrass), Steven Zeman, Andreas Wolf, Sandra Bruckmaier
  • Publication number: 20160130338
    Abstract: The present invention relates to a human monoclonal antibody or fragment thereof which specifically binds to and neutralizes primate GM-CSF.
    Type: Application
    Filed: May 21, 2015
    Publication date: May 12, 2016
    Inventors: Tobias Raum, Julia Hepp (nee Henckel), Eva Vieser (nee Krinner), Silke Petsch (nee Mittelstrass), Steven Zeman, Andreas Wolf, Sandra Bruckmaier
  • Patent number: 9067993
    Abstract: The present invention relates to a human monoclonal antibody or fragment thereof which specifically binds to and neutralizes primate GM-CSF.
    Type: Grant
    Filed: August 4, 2011
    Date of Patent: June 30, 2015
    Assignee: AMGEN RESEARCH (MUNICH) GMBH
    Inventors: Tobias Raum, Julia Hepp, Eva Vieser, Silke Petsch, Steven Zeman, Andreas Wolf, Sandra Bruckmaier
  • Publication number: 20120009195
    Abstract: The present invention relates to a human monoclonal antibody or fragment thereof which specifically binds to and neutralizes primate GM-CSF.
    Type: Application
    Filed: August 4, 2011
    Publication date: January 12, 2012
    Applicant: MICROMET AG
    Inventors: TOBIAS RAUM, JULIA HEPP (NEE HENCKEL), EVA VIESER (NEE KRINNER, SILKE PETSCH (NEE MITTELSTRASS), STEVEN ZEMAN, ANDREAS WOLF, SANDRA BRUCKMAIER
  • Patent number: 8017748
    Abstract: The present invention relates to a human monoclonal antibody or fragment thereof which specifically binds to and neutralizes primate GM-CSF.
    Type: Grant
    Filed: April 18, 2006
    Date of Patent: September 13, 2011
    Assignee: Micromet AG
    Inventors: Tobias Raum, Julia Hepp (Nee Henckel), Eva Vieser (Nee Krinner), Silke Petsch (Nee Mittelstrass), Steven Zeman, Andreas Wolf, Sandra Bruckmaier
  • Publication number: 20080312411
    Abstract: The invention relates to a use of an activated polymer to separate a non-covalently associated polypeptide multimer comprising multiple polypeptide subunits into multiple polypeptide subunits.
    Type: Application
    Filed: February 15, 2006
    Publication date: December 18, 2008
    Inventors: Andreas Wolf, Patrick Hoffmann, Julia Hepp Nee Henckel, Tobias Raum